Literature DB >> 15095273

Multiparameter DNA flow-sorting demonstrates diploidy and SDHD wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component.

Pieter B Douwes Dekker1, Willem E Corver, Pancras C W Hogendoorn, Andel G L van der Mey, Cees J Cornelisse.   

Abstract

Head and neck paragangliomas are considered to be biphasic tumours, composed of two distinct cell types: chief cells and sustentacular cells. A substantial number of these tumours show mutations in the SDHD gene located at chromosome 11q23. Although there is general agreement that paragangliomas are a neoplastic proliferation of chief cells, the nature of sustentacular cells is still a matter of debate. To clarify the nature of sustentacular cells further, multiparameter DNA flow cytometry was performed utilizing S-100 labelling as a selective marker of the sustentacular fraction simultaneously with DNA content measurement in six head and neck paragangliomas. S-100-positive fractions and other tumour-cell populations were flow-sorted and restriction digestion analysis of SDHD mutations was performed on each fraction. Flow cytometry demonstrated that the S-100 labelled cells were diploid. Restriction digestion analysis in informative cases revealed retention of the wild-type SDHD allele in S-100-positive fractions and loss of the wild-type allele in S-100-negative fractions. These data strongly suggest that sustentacular cells should be regarded as a non-neoplastic cell population that may be induced as a tumour-specific stromal component by chief cells. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095273     DOI: 10.1002/path.1535

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Pathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG Mice.

Authors:  James F Powers; Karel Pacak; Arthur S Tischler
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 2.  Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.

Authors:  Graeme Eisenhofer; Arthur S Tischler; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

3.  Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.

Authors:  Magnus Zethoven; Luciano Martelotto; Andrew Pattison; Blake Bowen; Shiva Balachander; Aidan Flynn; Fernando J Rossello; Annette Hogg; Julie A Miller; Zdenek Frysak; Sean Grimmond; Lauren Fishbein; Arthur S Tischler; Anthony J Gill; Rodney J Hicks; Patricia L M Dahia; Roderick Clifton-Bligh; Karel Pacak; Richard W Tothill
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

4.  Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells.

Authors:  Ana M Cervera; Jean-Pierre Bayley; Peter Devilee; Kenneth J McCreath
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

5.  Familial cervical paragangliomas with lymph node metastasis expressing somatostatin receptor type 2A.

Authors:  Noriko Kimura; Hiroo Tateno; Shigeru Saijo; Akira Horii
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

6.  Paragangliomas and paraganglioma syndromes.

Authors:  Carsten Christof Boedeker
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

7.  Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.

Authors:  Marc Bennedbæk; Maria Rossing; Åse K Rasmussen; Anne-Marie Gerdes; Anne-Bine Skytte; Uffe B Jensen; Finn C Nielsen; Thomas V O Hansen
Journal:  Hered Cancer Clin Pract       Date:  2016-06-08       Impact factor: 2.857

8.  Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.

Authors:  Attje S Hoekstra; Marieke A de Graaff; Inge H Briaire-de Bruijn; Cor Ras; Reza Maleki Seifar; Ivonne van Minderhout; Cees J Cornelisse; Pancras C W Hogendoorn; Martijn H Breuning; Johnny Suijker; Esther Korpershoek; Henricus P M Kunst; Norma Frizzell; Peter Devilee; Jean-Pierre Bayley; Judith V M G Bovée
Journal:  Oncotarget       Date:  2015-11-17

9.  Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis.

Authors:  Erik F Hensen; Jelle J Goeman; Jan Oosting; Andel G L Van der Mey; Pancras C W Hogendoorn; Cor W R J Cremers; Peter Devilee; Cees J Cornelisse
Journal:  BMC Med Genomics       Date:  2009-05-11       Impact factor: 3.063

10.  Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.

Authors:  Jean-Pierre Bayley; Rogier A Oldenburg; Jennifer Nuk; Attje S Hoekstra; Conny A van der Meer; Esther Korpershoek; Barbara McGillivray; Eleonora P M Corssmit; Winand N M Dinjens; Ronald R de Krijger; Peter Devilee; Jeroen C Jansen; Frederik J Hes
Journal:  BMC Med Genet       Date:  2014-10-10       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.